EPIRUS Biopharmaceuticals Mutual Funds

Health Care & Life Sciences » Biotechnology | EPIRUS Biopharmaceuticals Inc.

EPIRUS Biopharmaceuticals Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

19,958

0.08%

19,958

12/31/2016

BlackRock Master Small Cap Growth Portfolio

6,060

0.02%

01/31/2018

BlackRock Small Cap Growth Equity Portfolio

6,060

0.02%

05/31/2018

BlackRock (Japan) US Small Cap Growth Equity Open Mother Fund

702

09/20/2016

View Profile

Address	699 Boylston Street Boston Massachusetts 02116 United States
Employees	-
Website	http://www.epirusbiopharma.com
Updated	07/08/2019
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company focused on building a pure-play, sustainable and profitable biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded on November 26, 2008 and is headquartered in Boston, MA.